Recursion Pharmaceuticals Inc.

RXRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.99

+$0.02 (+0.50%)

Sep 22, 2026, 10:26 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Cash & Equivalents	545.68M	654.47M	743.29M	659.84M	528.22M	500.45M	594.35M	427.65M	474.34M	299.52M	391.57M	387.32M	405.87M	473.15M	549.91M	454.65M	453.88M	507.89M	285.12M	394.72M	632.74M	214.09M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	61.56M	83.21M	231.45M	184.19M	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	5.63M	n/a	n/a	n/a	n/a	6.63M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	17.94M	17.44M	18.79M	18.83M	9.42M	20.41M	14.45M	6.99M	6.94M	254K	6.89M	7.78M	7.74M	8M	7.92M	8.15M	8.33M	8.75M	8.72M	35K	68K	3.07M
Receivables	14.39M	13.59M	24.65M	21.91M	21.61M	46.12M	49.17M	2.26M	2.53M	2.6M	3.09M	3.16M	3.05M	2.06M	2.75M	11.64M	11.68M	11.4M	9.09M	2.28M	49K	71K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	34.71M	29.76M	33.16M	32.36M	37.34M	37.57M	70.75M	44.27M	45.51M	41.5M	43.48M	20.04M	22.1M	16.92M	17.15M	15.34M	18.88M	16.95M	9.07M	19.68M	14.85M	7.66M
Total Current Assets	603.46M	709.56M	812.85M	714.11M	587.16M	584.15M	714.27M	474.17M	522.38M	343.62M	438.14M	410.52M	431.02M	492.13M	569.81M	481.62M	546M	619.46M	534.72M	600.87M	647.64M	221.82M
Property-Plant & Equipment	147.07M	157.32M	169.48M	181.24M	193.6M	204.78M	233.21M	159.19M	156.28M	122.22M	120.17M	120.31M	124.67M	125.12M	121.45M	119.5M	116.15M	104.01M	64.73M	55.44M	48.55M	44.64M
Goodwill & Intangibles	443.24M	454.24M	472.06M	484.39M	505.59M	493.9M	484.73M	86.15M	90.27M	85.13M	88.5M	92.21M	103.27M	2.12M	2.11M	2.26M	2.03M	2.11M	2.19M	2.26M	2.34M	2.41M
Total Long-Term Assets	609.21M	629.97M	661.29M	685.42M	715.2M	721.09M	734.33M	252.33M	253.49M	214.23M	215.56M	220.3M	235.68M	135.24M	131.47M	129.92M	126.52M	114.86M	75.63M	57.74M	50.96M	50.12M
Total Assets	1.21B	1.34B	1.47B	1.4B	1.3B	1.31B	1.45B	726.5M	775.86M	557.85M	653.7M	630.83M	666.7M	627.37M	701.29M	611.53M	672.52M	734.32M	610.35M	658.61M	698.59M	271.94M
Account Payables	12.67M	20.35M	18.12M	13.94M	19.31M	25.09M	21.61M	2.26M	3.76M	5.12M	3.95M	4.27M	2.09M	4.25M	4.59M	3.89M	3.18M	4.16M	2.82M	6.33M	3.2M	3.13M
Deferred Revenue	27.59M	32.79M	37.61M	47.36M	39.69M	39.65M	61.77M	49.58M	32.2M	36.62M	36.43M	44M	73.11M	57.76M	56.73M	46.75M	63.78M	54.25M	10M	10M	10M	10M
Short-Term Debt	n/a	9.27M	9.09M	8.92M	8.75M	8.59M	8.43M	8.22M	8.11M	55K	41K	695K	676K	661K	97K	95K	93K	92K	90K	88K	3.14M	2.15M
Other Current Liabilities	n/a	14.57M	31.77M	24.06M	1.54M	22.46M	50.85M	19.66M	13.12M	16.02M	22.89M	22.23M	15.85M	10.24M	20.43M	11.81M	8M	5.92M	11.74M	7.26M	4.4M	1.8M
Total Current Liabilities	119.89M	129.7M	147.71M	155.1M	164.03M	141.98M	187.47M	108.89M	86.08M	73.92M	93.17M	94.12M	113.96M	92.15M	100.27M	83.04M	96.65M	85.71M	46.66M	42.94M	29.54M	26.85M
Long-Term Debt	n/a	7.18M	9.56M	11.9M	14.2M	16.45M	19.02M	20.51M	22.92M	1.07M	1.1M	1.13M	1.16M	1.18M	536K	561K	586K	610K	633K	656K	9.42M	10.34M
Other Long-Term Liabilities	7.46M	2.03M	2.08M	1.03M	1.57M	4.79M	4.73M	3M	3M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.11M	3.35M	2.82M	451.06M
Total Long-Term Liabilities	177.78M	185.05M	195.56M	197.48M	219.18M	229.31M	226.34M	93.05M	105.33M	82.78M	97.09M	98.74M	83.78M	105.04M	115.22M	140.46M	138.28M	155.05M	20.75M	16.63M	26.34M	478.12M
Total Liabilities	297.67M	314.75M	343.27M	352.58M	383.21M	371.29M	413.82M	201.94M	191.41M	156.7M	190.26M	192.86M	197.74M	197.19M	215.48M	223.5M	234.94M	240.75M	67.41M	59.57M	55.88M	504.97M
Total Debt	61.89M	72.38M	77.97M	82.37M	88.08M	92.91M	108.49M	90.63M	89.88M	50.97M	50.67M	51.48M	52.9M	53.05M	51.01M	52.19M	53.68M	52.11M	11.48M	5.62M	15.48M	15.54M
Book Value	915M	1.02B	1.13B	1.05B	919.15M	933.95M	1.03B	524.56M	584.45M	401.15M	463.44M	437.97M	468.96M	430.18M	485.81M	388.03M	437.58M	493.57M	542.94M	599.03M	642.71M	-233.03M
Book Value Per Share	1.72	1.94	2.15	2.34	2.20	2.32	3.08	1.86	2.41	1.70	1.99	2.04	2.33	2.24	2.62	2.24	2.54	2.89	3.21	3.55	3.82	-1.38
Common Stock	5K	5K	5K	5K	4K	4K	4K	3K	3K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	n/a
Retained Earnings	-2.32B	-2.19B	-2.08B	-1.97B	-1.81B	-1.63B	-1.43B	-1.25B	-1.16B	-1.06B	-967.62M	-874.63M	-781.61M	-704.88M	-639.56M	-582.06M	-521.62M	-456.06M	-400.08M	-335.15M	-287.72M	-244.32M
Comprehensive Income	27.99M	26.66M	36.72M	34.09M	43.62M	14.15M	-7.64M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-197K	-309K	-126K	2K	n/a	n/a
Shareholders Equity	915M	1.02B	1.13B	1.05B	919.15M	933.95M	1.03B	524.56M	584.45M	401.15M	463.44M	437.97M	468.96M	430.18M	485.81M	388.03M	437.58M	493.57M	542.94M	599.03M	642.71M	-233.03M
Total Investments	n/a	n/a	n/a	n/a	5.63M	n/a	n/a	n/a	n/a	6.63M	n/a	n/a	n/a	n/a	n/a	n/a	61.56M	83.21M	231.45M	184.19M	n/a	n/a